Although EGFR,45 CCND1,39 MYC, FGFR1,46,47 and PIK3CA amplification have been reported by a number of studies on HNSCC, their role as a prognostic marker with or without the presence of p16 infection is unclear. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.